期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Transforming growth factor-β1 and epidermal growth factor decrease the expression of 17β-hydroxysteroid dehy-drogenase type 2 in endo-metrial carcinoma cells
1
作者 Xiaohong Li Zhijie Xiao Yunshang Piao 《Chinese Science Bulletin》 SCIE EI CAS 2002年第1期43-47,共5页
Estradiol (E2) is the major molecular form of estrogens. Its biological effects are determined by estrogen receptors and intracellular E2 concentration in target cells. Regulation of intracellular E2 concentration inv... Estradiol (E2) is the major molecular form of estrogens. Its biological effects are determined by estrogen receptors and intracellular E2 concentration in target cells. Regulation of intracellular E2 concentration involves the action of 17p-hydroxysteroid dehydrogenase (17HSD) type 2, the enzyme inactivating E2 to estrone. It has been demon-strated that 17HSD type 2 is expressed in normal endo-metrial epithelia and emdometrial carcinoma cells (RL 95-2). However, the regulatory mechanism of 17HSD type 2 expression in emdometrial cancer cells remains unknown. In the present study, the effects of transforming growth factor-β1 (TGF-β1) and epidermal growth factor (EGF) on 17HSD type 2 expression in RL 95-2 cells have been investigated using enzyme activity assay and Northern blot analysis. After stimulation with TGF-P1 or EGF, the in vivo oxidative 17HSD activity in RL 95-2 cells was significantly decreased. It appeared that the inhibitory effect of TGF-β1 and EGF onthe enzyme activity of 17HSD type 2 展开更多
关键词 emlometrium. ESTROGEN 17β-hydroxysteroid dehydro-genase GROWTH factor.
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部